Total Payments
$12,567
2024 Payments
$189.95
Companies
50
Transactions
212
Medicare Patients
9,740
Medicare Billing
$6.6M
Payment Breakdown by Category
Consulting$4,788 (38.1%)
Other$4,350 (34.6%)
Food & Beverage$3,397 (27.0%)
Education$32.41 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $4,788 | 5 | 38.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,350 | 5 | 34.6% |
| Food and Beverage | $3,397 | 198 | 27.0% |
| Education | $32.41 | 4 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $3,108 | 10 | $0 (2024) |
| GENZYME CORPORATION | $2,496 | 6 | $0 (2019) |
| Daiichi Sankyo Inc. | $2,062 | 4 | $0 (2022) |
| Rigel Pharmaceuticals, Inc. | $1,018 | 2 | $0 (2020) |
| COMSORT, Inc | $450.00 | 3 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $449.08 | 30 | $0 (2019) |
| Janssen Biotech, Inc. | $363.85 | 25 | $0 (2020) |
| Alexion Pharmaceuticals, Inc. | $251.00 | 2 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $183.88 | 11 | $0 (2019) |
| PFIZER INC. | $151.38 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $189.95 | 7 | ABBVIE INC. ($50.78) |
| 2023 | $3,168 | 8 | Merck Sharp & Dohme LLC ($3,000) |
| 2022 | $2,301 | 5 | Daiichi Sankyo Inc. ($2,000) |
| 2021 | $45.50 | 3 | GlaxoSmithKline, LLC. ($17.07) |
| 2020 | $1,059 | 5 | Rigel Pharmaceuticals, Inc. ($1,000) |
| 2019 | $3,065 | 41 | GENZYME CORPORATION ($2,447) |
| 2018 | $1,098 | 59 | Janssen Biotech, Inc. ($174.77) |
| 2017 | $1,640 | 84 | COMSORT, Inc ($300.00) |
All Payment Transactions
212 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/05/2024 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $20.49 | General |
| 09/27/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $34.23 | General |
| Category: ONCOLOGY | ||||||
| 09/26/2024 | Invivyd Inc | PEMGARDA (Biological) | Food and Beverage | In-kind items and services | $35.07 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/17/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: ONCOLOGY | ||||||
| 09/11/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $26.21 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 07/02/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), REBLOZYL, WELIREG | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: ONCOLOGY | ||||||
| 04/05/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $26.01 | General |
| Category: ONCOLOGY | ||||||
| 08/01/2023 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $18.96 | General |
| Category: Hematology | ||||||
| 07/24/2023 | Merck Sharp & Dohme LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| 06/09/2023 | Pharmacyclics LLC, An AbbVie Company | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $26.06 | General |
| Category: ONCOLOGY | ||||||
| 04/19/2023 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/30/2023 | Amgen Inc. | Blincyto (Biological), Kyprolis | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Oncology | ||||||
| 03/29/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $29.13 | General |
| Category: ONCOLOGY | ||||||
| 03/18/2023 | ARGON MEDICAL DEVICES, INC. | CLEANER (Device) | Food and Beverage | Cash or cash equivalent | $50.47 | General |
| Category: VASCULAR | ||||||
| 03/09/2023 | Merck Sharp & Dohme LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| 11/22/2022 | Daiichi Sankyo Inc. | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 10/27/2022 | Pharmacyclics LLC, an AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: ONCOLOGY | ||||||
| 09/13/2022 | Alexion Pharmaceuticals, Inc. | — | Education | In-kind items and services | $1.00 | General |
| 05/18/2022 | Pharmacyclics LLC, an AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $25.37 | General |
| Category: ONCOLOGY | ||||||
| 03/09/2022 | Alexion Pharmaceuticals, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $250.00 | General |
| 11/04/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 01/22/2021 | GlaxoSmithKline, LLC. | BLENREP (Biological) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: ONCOLOGY | ||||||
| 12/19/2020 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $14.22 | General |
| Category: Hematology/Oncology | ||||||
| 11/25/2020 | Puma Biotechnology, Inc. | NERLYNX (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 39 | 2,223 | 104,938 | $6.8M | $1.9M |
| 2022 | 59 | 3,305 | 189,979 | $10.7M | $3.0M |
| 2021 | 46 | 2,813 | 113,186 | $5.7M | $1.6M |
| 2020 | 25 | 1,399 | 3,731 | $450,302 | $163,648 |
Total Patients
9,740
Total Services
411,834
Medicare Billing
$6.6M
Procedure Codes
173
All Medicare Procedures & Services
173 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | Office | 2023 | 23 | 31,000 | $3.9M | $1.3M | 34.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 24 | 7,140 | $364,140 | $130,865 | 35.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 244 | 740 | $215,633 | $76,935 | 35.7% |
| J1437 | Injection, ferric derisomaltose, 10 mg | Office | 2023 | 37 | 4,600 | $344,400 | $76,398 | 22.2% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 85 | 637 | $436,982 | $68,796 | 15.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 418 | 603 | $111,285 | $39,648 | 35.6% |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 2023 | 14 | 11,095 | $232,995 | $24,819 | 10.7% |
| J0185 | Injection, aprepitant, 1 mg | Office | 2023 | 29 | 15,600 | $140,400 | $21,374 | 15.2% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 16 | 244 | $50,020 | $15,075 | 30.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 417 | 1,781 | $62,335 | $13,497 | 21.7% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 54 | 408 | $62,016 | $9,768 | 15.8% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 75 | 182 | $55,328 | $9,591 | 17.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 69 | 69 | $26,979 | $8,952 | 33.2% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 55 | 669 | $70,245 | $8,671 | 12.3% |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 2023 | 19 | 21,420 | $107,100 | $8,610 | 8.0% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2023 | 30 | 141 | $47,094 | $7,695 | 16.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 61 | 88 | $17,844 | $6,040 | 33.8% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 30 | 190 | $29,640 | $4,461 | 15.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 82 | 382 | $35,526 | $4,292 | 12.1% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2023 | 11 | 198 | $19,206 | $3,423 | 17.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 22 | $8,520 | $3,297 | 38.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 17 | 17 | $8,954 | $3,031 | 33.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 34 | 34 | $8,178 | $2,901 | 35.5% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 17 | 20 | $5,820 | $2,127 | 36.6% |
| 96360 | Infusion into a vein for hydration, 31-60 minutes | Office | 2023 | 20 | 69 | $17,181 | $1,753 | 10.2% |
About Dr. Ravin Garg, M.D
Dr. Ravin Garg, M.D is a Hematology & Oncology healthcare provider based in Annapolis, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043385180.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ravin Garg, M.D has received a total of $12,567 in payments from pharmaceutical and medical device companies, with $189.95 received in 2024. These payments were reported across 212 transactions from 50 companies. The most common payment nature is "Consulting Fee" ($4,788).
As a Medicare-enrolled provider, Garg has provided services to 9,740 Medicare beneficiaries, totaling 411,834 services with total Medicare billing of $6.6M. Data is available for 4 years (2020–2023), covering 173 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Annapolis, MD
- Active Since 11/22/2006
- Last Updated 02/05/2014
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1043385180
Products in Payments
- JEVTANA (Drug) $2,457
- Tavalisse (Drug) $1,000
- KEYTRUDA (Biological) $545.23
- IMBRUVICA (Drug) $196.64
- OPDIVO (Biological) $125.91
- ELITEK (Drug) $121.75
- DARZALEX (Biological) $106.40
- XARELTO (Drug) $98.03
- XTANDI (Drug) $94.36
- GILOTRIF (Drug) $90.93
- Erleada (Drug) $82.12
- AFINITOR (Drug) $78.22
- TASIGNA (Drug) $75.31
- JAKAFI (Drug) $74.75
- JADENU (Drug) $64.72
- Revlimid (Drug) $62.60
- INJECTAFER (Drug) $62.08
- ZYTIGA (Drug) $58.20
- ADCETRIS (Biological) $55.48
- KISQALI (Drug) $55.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Annapolis
Carol Tweed, Md, MD
Hematology & Oncology — Payments: $129,960
Hematology & Oncology $129,960
Arun Bhandari, Md, MD
Hematology & Oncology — Payments: $117,827
Hematology & Oncology $117,827
Dr. Peter Graze, M.d, M.D
Hematology & Oncology — Payments: $11,731
Hematology & Oncology $11,731
Dr. Jeanine Werner, M.d, M.D
Hematology & Oncology — Payments: $8,620
Hematology & Oncology $8,620
Dr. Stuart Selonick, M.d, M.D
Hematology & Oncology — Payments: $6,239
Hematology & Oncology $6,239
Dr. Benjamin Bridges, Md, MD
Hematology & Oncology — Payments: $4,035
Hematology & Oncology $4,035